Harbour Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.1K	Buy	122 +42	+53%	+$5.57K	﹤0.01%	3004
2025 Q4	$11.3K	Sell	80 -32	-29%	-$4.64K	﹤0.01%	2683
2025 Q3	$15.7K	Hold	112	–	–	﹤0.01%	2469
2025 Q2	$14.1K	Buy	112 +93	+489%	+$10.7K	﹤0.01%	2395
2025 Q1	$2.1K	Sell	19 -2	-10%	-$253	﹤0.01%	3076
2024 Q4	$2.87K	Sell	21 -7	-25%	-$866	﹤0.01%	2910
2024 Q3	$3.23K	Buy	28 +9	+47%	+$1.23K	﹤0.01%	2778
2024 Q2	$2.62K	Sell	19 -11	-37%	-$1.51K	﹤0.01%	2734
2024 Q1	$4.14K	Buy	30 +4	+15%	+$546	﹤0.01%	2566
2023 Q4	$3.43K	Hold	26	–	–	﹤0.01%	2539
2023 Q3	$2.92K	Buy	26 +10	+63%	+$1.05K	﹤0.01%	2447
2023 Q2	$1.51K	Buy	16 +5	+45%	+$489	﹤0.01%	2618
2023 Q1	$1.11K	Hold	11	–	–	﹤0.01%	2674
2022 Q4	$1.31K	Buy	11 +9	+450%	+$1.05K	﹤0.01%	2628
2022 Q3	$0	Hold	2	–	–	﹤0.01%	2793
2022 Q2	$0	Buy	+2	New	+$185	﹤0.01%	2793
2021 Q4	$0	Sell	2 -110	-98%	-$10.1K	﹤0.01%	3322
2021 Q3	$11K	Buy	112 +7	+7%	+$661	﹤0.01%	2617
2021 Q2	$10K	Sell	105 -46	-30%	-$4.41K	﹤0.01%	2738
2021 Q1	$15K	Buy	+151	New	+$15.8K	﹤0.01%	2374